Interview with Janet Woodcock
- PMID: 21083281
- DOI: 10.4155/bio.10.113
Interview with Janet Woodcock
Abstract
Dr Janet Woodcock is the Director of the US FDA's Center for Drug Evaluation and Research. Dr Woodcock has held various positions within the FDA's Office of the Commissioner from October 2003 until 1 April 2008, as Deputy Commissioner and Chief Medical Officer, Deputy Commissioner for Operations and Chief Operating Officer and Director of the Critical Path Programs. She oversaw scientific and medical regulatory operations for the FDA. Dr Woodcock served as Director of the Center for Drug Evaluation and Research at the FDA from 1994 to 2005. She previously served in other positions at the FDA, including Director of the Office of Therapeutics Research and Review and Acting Deputy Director of the Center for Biologics Evaluation and Research. Dr Woodcock received her MD from Northwestern Medical School (IL, USA), and completed further training and held teaching appointments at the Pennsylvania State University (PA, USA) and the University of California in San Francisco (CA, USA). She joined the FDA in 1986.
Similar articles
-
Interview with Janet Woodcock: progress on the FDA's critical path initiative.Biomark Med. 2009 Dec;3(6):671-3. doi: 10.2217/bmm.09.72. Biomark Med. 2009. PMID: 20477704
-
Janet Woodcock discusses the FDA and the drug development process. Interview by Christopher Watson.Drug Discov Today. 2004 Jul 1;9(13):548-50. doi: 10.1016/S1359-6446(04)03160-5. Drug Discov Today. 2004. PMID: 15203087
-
Lessons learned from independent central review.Eur J Cancer. 2009 Jan;45(2):268-74. doi: 10.1016/j.ejca.2008.10.031. Eur J Cancer. 2009. PMID: 19101138
-
Food and Drug Administration requirements for testing and approval of new radiopharmaceuticals.Semin Nucl Med. 2010 Sep;40(5):364-84. doi: 10.1053/j.semnuclmed.2010.05.002. Semin Nucl Med. 2010. PMID: 20674596 Review.
-
Food and Drug Administration approval process for ophthalmic drugs in the US.Curr Opin Ophthalmol. 2008 May;19(3):190-4. doi: 10.1097/ICU.0b013e3282f97fa1. Curr Opin Ophthalmol. 2008. PMID: 18408492 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous